We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
APOHIDE (Accelagen Pty Ltd)
Product name
APOHIDE
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
215 (255 working days)
Active ingredients
oxybutynin hydrochloride
Registration type
EOI
Indication
The approved indication for this therapeutic good is:
- APOHIDE® is indicated for the treatment of primary palmar hyperhidrosis.